IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management IV, LLC

Q1 2019 Holdings

Filed 2019-05-14 | 16 holdings | $45.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ascendis Pharma A/S(ASND)SPONSORED ADR04351P101$28.9M245,42462.9%
Cytokinetics Incorporated(CYTK)COM NEW23282W605$13.9M1,723,17030.3%
Arbutus Biopharma Corporation(ABUS)COM03879J100$2.9M804,4466.3%
Insmed Incorporated(INSM)COM457669307$44.6K1,533,8830.1%
CymaBay Therapeutics, Inc.(CBAYUSD)COM23257D103$34.9K2,631,2580.1%
Biohaven Pharmaceutical Holding Company Ltd.(BHVN)COMG11196105$26.7K518,5600.1%
OptiNose, Inc.COM68404V100$25.0K2,427,4030.1%
Immunomedics, Inc.(IMMU)COM452907108$22.3K1,161,9650.0%
Myokardia, Inc.COM62857M105$20.0K384,9930.0%
Replimune Group, Inc.(REPL)COM76029N106$18.7K1,229,6560.0%
Rhythm Pharmaceuticals, Inc.(RYTM)COM76243J105$11.1K405,0260.0%
Alector, Inc.(ALEC)COM014442107$10.7K1,203,4620.0%
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$10.1K211,8230.0%
Si-Bone, Inc.(SIBN)COM825704109$3.9K205,6210.0%
Voyager Therapeutics, Inc.(VYGR)COM92915B106$3.4K177,8040.0%
Kiniksa Pharmaceuticals, Ltd.Class A CommonG5269C101$1.2K63,9220.0%